» Articles » PMID: 33219038

Neuromyelitis Optica Spectrum Disorder: Pregnancy-related Attack and Predictive Risk Factors

Overview
Date 2020 Nov 21
PMID 33219038
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: To investigate the influence of pregnancy on patients with neuromyelitis optica spectrum disorder (NMOSD) and to identify risk factors that predict pregnancy-related attack.

Methods: From January 2015 to April 2019, 418 female patients with NMOSD were registered at Huashan Hospital. We retrospectively reviewed their medical records and identified 110 patients with 136 informative pregnancies, of whom 83 were aquaporin-4 antibody (AQP4-ab)-positive and 21 were myelin oligodendrocyte glycoprotein-antibody-positive. Pregnancy-related attack was defined as an attack that occurred during pregnancy or within 1 year after delivery/abortion. We compared annualised relapse rate (ARR) during 12 months before pregnancy with that during every trimester of pregnancy and after delivery/abortion. Multivariate analyses were used to explore the independent risk factors involved and a nomogram was generated for the prediction of pregnancy-related attack. Thirty-five female patients from 3 other centres formed an external cohort to validate this nomogram.

Results: ARR increased significantly during the first trimester after delivery (p<0.001) or abortion (p=0.019) compared with that before pregnancy. Independent risk factors predicting pregnancy-related attack included age at delivery/abortion (20-26.5, p=0.018; 26.5-33, p=0.001), AQP4-ab titre (≥1:100, p=0.049) and inadequate treatment during pregnancy and postpartum period (p=0.004). The concordance index of nomogram was 0.87 and 0.77 using bootstrap resampling in internal and external validation.

Conclusions: The first trimester post partum is a high-risk period for NMOSD recurrence. Patients with younger age, higher AQP4-ab titre and inadequate treatment are at higher risk for pregnancy-related attack.

Citing Articles

Insights into neuromyelitis optica spectrum disorder and pregnancy from a single-center study in Thailand.

Budtarad N, Ongphichetmehta T, Siritho S Sci Rep. 2025; 15(1):4011.

PMID: 39893222 PMC: 11787356. DOI: 10.1038/s41598-025-88624-x.


Is there a prodrome to NMOSD? An investigation of neurologic symptoms preceding the first NMOSD attack.

Lee S, Marrie R, Fadda G, Freedman M, Lee L, Muccilli A Mult Scler. 2024; 30(11-12):1423-1435.

PMID: 39258406 PMC: 11529114. DOI: 10.1177/13524585241275491.


Sex hormones and neuromyelitis optica spectrum disorder: a bidirectional Mendelian randomization study.

Hu Y, Zou F, Lu W Neurol Sci. 2024; 45(9):4471-4479.

PMID: 38565746 DOI: 10.1007/s10072-024-07501-z.


Skin Manifestations of Neuromyelitis Optica Spectrum Disorder With Secondary Systemic Lupus Erythematosus During Pregnancy: A Three-Year Follow-Up.

Bolakale-Rufai I, Chukwuocha I, Makanjuola A, Enigbokan O, Yaria J Cureus. 2023; 15(6):e40260.

PMID: 37440821 PMC: 10335814. DOI: 10.7759/cureus.40260.


Assessment of revascularization impact on microvascular oxygenation and perfusion using spatial frequency domain imaging.

Bolakale-Rufai I, Thompson M, Concha-Moore K, Jett S, Awasthi S, Cuccia D J Surg Case Rep. 2023; 2023(7):rjad382.

PMID: 37426041 PMC: 10329471. DOI: 10.1093/jscr/rjad382.


References
1.
Borchers A, Naguwa S, Keen C, Gershwin M . The implications of autoimmunity and pregnancy. J Autoimmun. 2009; 34(3):J287-99. DOI: 10.1016/j.jaut.2009.11.015. View

2.
Huang Y, Wang Y, Zhou Y, Huang Q, Sun X, Chen C . Pregnancy in neuromyelitis optica spectrum disorder: A multicenter study from South China. J Neurol Sci. 2016; 372:152-156. DOI: 10.1016/j.jns.2016.11.054. View

3.
Wuebbolt D, Nguyen V, DSouza R, Wyne A . Devic syndrome and pregnancy: A case series. Obstet Med. 2018; 11(4):171-177. PMC: 6295766. DOI: 10.1177/1753495X18758868. View

4.
Kitley J, Waters P, Woodhall M, Leite M, Murchison A, George J . Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study. JAMA Neurol. 2014; 71(3):276-83. DOI: 10.1001/jamaneurol.2013.5857. View

5.
Touijer K, Scardino P . Nomograms for staging, prognosis, and predicting treatment outcomes. Cancer. 2009; 115(13 Suppl):3107-11. DOI: 10.1002/cncr.24352. View